Company / Shareholders' Equity
BioLife Solutions, Inc. Shareholders' Equity History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$371.9M
FY2025
5-year range
$337.7M / $478.0M
FY2021-FY2025
Trend
+6.6%
vs FY2024
Sector context
#120 of 166
Health Care
What the data says
At $372M, BioLife Solutions, Inc.'s shareholders' equity ranks #120 of 166 in the Health Care sector. Shareholders' Equity has fluctuated over the past 10 years, ranging from -$10M in FY2017 to $478M in FY2021.
Based on SEC 10-K filings.
$372M in FY2025 with a 5-year CAGR of +12.7%.
Improved from $338M to $372M over the past 2 years.
Health Care sector context is included.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- +0.7%
- 5-Year CAGR
- +12.7%
- 10-Year CAGR
- -
Sector benchmark
#120 of 166 in Health CareTop 72% of 166This company $371.9M Sector average $5.3B
▼
-92.9% below sector average
Key checks
Key Insights
- 5-year CAGR of +12.7%, indicating consistent growth.
- In FY2025, shareholders' equity increased 6.6% year-over-year.
- Ranks #120 out of 166 companies in the Health Care sector.
- Peak shareholders' equity was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score 4.67 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $371.9M | +6.6% |
| FY2024 | $348.9M | +3.3% |
| FY2023 | $337.7M | -7.3% |
| FY2022 | $364.2M | -23.8% |
| FY2021 | $478.0M | +133.8% |
| FY2020 | $204.4M | +371.9% |
| FY2019 | $43.3M | +196.1% |
| FY2018 | $14.6M | +253.5% |
| FY2017 | -$9.5M | -401.0% |
| FY2016 | $3.2M | -62.8% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026